Results for: drugmaker

Actavis, Sanofi among bidders for Omega Pharma- Bloomberg

Shire CFO to leave drugmaker as AbbVie drops bid

AbbVie says $55 billion acquisition of Shire officially dead

Novartis reports positive results in spinal inflammation condition

Drugmakers may need indemnity for fast-tracked Ebola vaccines

GSK sees first Ebola vaccine doses ready late this year

Roche to spend $3.2 billion on towering Basel base

FTSE 100 rebounds, GKN gains after results

Exclusive - EU earmarks $250 million to help develop Ebola vaccines:...

Fixing 'Ebolanomics' in pursuit of vaccines and drugs

AbbVie says $55 billion acquisition of Shire officially dead

Private equity eyes 10 billion-euro Bayer plastics business - sources

J&ampJ and GSK step up Ebola vaccine race

Exclusive: Fresenius, buyout groups eye Danone Medical Nutrition unit -...

Drug companies step up Ebola vaccine race

U.S. stocks drop AT&ampT earns miss